How much revenue does Medico Intercontinental make?

Medico Intercontinental reported 960.15 million INR in revenue for fiscal year 2025, up 34.6% from 713.55 million INR in fiscal year 2024. In Q3 2026 revenue was 198.48 million INR.

What companies are similar to Medico Intercontinental?

Listed companies of a similar size in the same industry (multi-therapeutic drug manufacturing) include Bharat Immunologicals & Biologicals Corporation Limited (BIBCL.BO), Gujarat Terce Laboratories Limited (GUJTERC.BO), Chandra Bhagat Pharma Ltd (CBPL.BO), Welcure Drugs and Pharmaceuticals Limited (WELCURE.BO).

Medico Intercontinental Limited (MIL.BO) Stock

About Medico Intercontinental Limited

Medico Intercontinental Limited engages in the trading of pharmaceutical products. It offers products in the gastro, uro, nutrition, cosmetology, and other areas, as well as provides health devices and hospital related products. The company also provides general and derma range products in various forms, such as tablets, soft gelatine, capsules, dental, ointments, powders and sprays, liquids, ayur...

At a glance

Medico Intercontinental reported revenue of 960.15 million INR for fiscal year 2025, up 34.6% from fiscal year 2024, and net income of 50.57 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 198.48 million INR, up 3.6% from a year before.

Figures from company filings; latest fiscal year ended March 31, 2025.

No profile data available.

Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.